Recruiting

Biologic Mesh

Sponsor:

New York Medical College

Code:

NCT04780048

Conditions

Hernia

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

The purpose of this study is to determine how the patient factors, co-morbid conditions, pre-operative workup, anatomy of the defect, reconstruction details, operative techniques, and type of repairs contribute to the final outcome of abdominal wall reconstruction. The outcomes of interest are: in-hospital complications, discharge disposition, hospital and ICU length of stay, long term follow-up (recurrence, reoperation, and explantation rates).

Conditions

Hernia

Study ID

NCT04780048

Start date

Jul 7, 2017

Status verified date

Mar, 2021

Completion date

Dec 6, 2022

Anticipated

Primary completion date

Jul 6, 2022

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Inclusion Criteria:

• All patients aged 18 years and above undergoing Abdominal wall reconstruction with biological mesh.

Exclusion Criteria:

• Vulnerable patient population (Neonates, Prisoners, Pregnant) will not be included in our study

Study Design

Enrollment

250 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • In Hospital Complications [ Time Frame: 3 years ]

Central Contacts and Locations

Central contacts

Agon Kajmolli, MD

9144937936agon.kajmolli@wmchealth.org

Matthew McGuirk, MD

9144937936Matthew.McGuirk@wmchealth.org

Locations

Westchester Medical center

Recruiting

Valhalla, New York, United States, 10595

Contacts

Agon Kajmolli, MD

914-493-7936agon.kajmolli@wmchealth.org

Matthew McGuirk, MD

9144937936Matthew.McGuirk@wmchealth.org

Principal Investigator:

Rifat Latifi, MD

More Information

Sponsor

New York Medical College

Last update posted

Mar 3, 2021

Last verified

Mar, 2021

Keywords

  • Hernia repair

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by New York Medical College on 2021-03-03.